Published November 13, 2019
Calvin Meaney (PharmD ’11), clinical associate professor, pharmacy practice, was selected as this year’s New York State Chapter of the American College of Clinical Pharmacy (ACCP) Researcher of the Year.
The NYS-ACCP Researcher of the Year Award recognizes outstanding contribution to the scientific literature of drug therapy by a pharmacist researcher in New York State involving scientific research that will be applicable to patient care.
Meaney was recognized at the NYS-ACCP Fall Clinical Meeting in Schenectady, N.Y.
“Dr. Meaney embodies the true spirit of excellence in clinical pharmacy research as an emerging pharmacist scientist and he makes our department and school very proud,” says Brian Tsuji, professor and associate dean, clinical and translational science.
Meaney is a clinical pharmacist-scientist in the field of nephrology. His research is focused on the optimization of drug therapy through the application of quantitative clinical pharmacology. He leads a multidisciplinary group of researchers to address novel personalization of erythropoiesis-stimulating agents in hemodialysis patients. Other work has focused on drug-induced nephrotoxicity where he was one of the first researchers to identify vancomycin and piperacillin/tazobactam as a nephrotoxic combination.
Meaney was recently honored with the 2018 and 2019 Faculty Member of the Year Award, as voted by the graduating PharmD classes, the 2019 Rho Chi Teaching Excellence Award and the 2018 Faculty Preceptor of the Year.
The American College of Clinical Pharmacy is a professional and scientific society that provides leadership, education, advocacy, and resources enabling clinical pharmacists to achieve excellence in practice, research, and education.